Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,045 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Definitions in hemophilia: communication from the SSC of the ISTH.
Blanchette VS, Key NS, Ljung LR, Manco-Johnson MJ, van den Berg HM, Srivastava A; Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders of the Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis. Blanchette VS, et al. Among authors: srivastava a. J Thromb Haemost. 2014 Nov;12(11):1935-9. doi: 10.1111/jth.12672. Epub 2014 Sep 3. J Thromb Haemost. 2014. PMID: 25059285 Free article. No abstract available.
Pharmacokinetics, clot strength and safety of a new fibrinogen concentrate: randomized comparison with active control in congenital fibrinogen deficiency.
Ross C, Rangarajan S, Karimi M, Toogeh G, Apte S, Lissitchkov T, Acharya S, Manco-Johnson MJ, Srivastava A, Brand B, Schwartz BA, Knaub S, Peyvandi F. Ross C, et al. Among authors: srivastava a. J Thromb Haemost. 2018 Feb;16(2):253-261. doi: 10.1111/jth.13923. Epub 2018 Jan 22. J Thromb Haemost. 2018. PMID: 29220876 Free article. Clinical Trial.
Joint WFH-ISTH session: issues in clinical trial design.
Peyvandi F, Farrugia A, Iorio A, Key NS, Srivastava A. Peyvandi F, et al. Among authors: srivastava a. Haemophilia. 2014 May;20 Suppl 4:137-44. doi: 10.1111/hae.12415. Haemophilia. 2014. PMID: 24762289 Review.
Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspective.
Fischer K, Poonnoose P, Dunn AL, Babyn P, Manco-Johnson MJ, David JA, van der Net J, Feldman B, Berger K, Carcao M, de Kleijn P, Silva M, Hilliard P, Doria A, Srivastava A, Blanchette V; participants of the International Symposium on Outcome Measures in Hemophilic Arthropathy. Fischer K, et al. Among authors: srivastava a. Haemophilia. 2017 Jan;23(1):11-24. doi: 10.1111/hae.13088. Epub 2016 Sep 15. Haemophilia. 2017. PMID: 27633342 Review.
The economics of haemophilia prophylaxis: governmental and insurer perspectives. Proceedings of the Second International Prophylaxis Study Group (IPSG) symposium.
Feldman BM, Aledort L, Bullinger M, Delaney FM, Doria AS, Funk S, Giangrande P, Lundin B, Manco-Johnson M, Miners A, Scriba PC, Srivastava A, Schramm W, Blanchette VS; Second International Prophylaxis Study Group. Feldman BM, et al. Among authors: srivastava a. Haemophilia. 2007 Nov;13(6):745-9. doi: 10.1111/j.1365-2516.2007.01542.x. Epub 2007 Sep 10. Haemophilia. 2007. PMID: 17850325 No abstract available.
7,045 results